Oncology (Solid Tumors)
Test No. |
Test Name |
Analytical Technique |
Sample required |
TAT |
ONCNGS168 |
BRAF V600 region sequencing |
NGS |
Paraffin block/ Fresh tissue |
4-5 weeks |
ONCNGS160 |
KRAS mutation analysis (codons 12, 13, 61 & 146) by NGS |
NGS |
Paraffin Block/ Fresh tissue |
4-5 weeks |
ONCNGS158 |
EGFR mutation analysis (exons 18, 19, 20 and 21) by NGS |
NGS |
Paraffin Block/ Fresh tissue |
4-5 weeks |
ONCNGS387 |
EGFR T790M Quantitative mutation detection by NGS |
NGS |
Paraffin Block/ Fresh tissue |
4-5 weeks |
ONCNGS236 |
EGFR (exons 18, 19, 20 and 21) and KRAS (codons 12, 13, 61 and 146) ultradeep mutation analysis by Next Generation Sequencing |
NGS |
Paraffin Block/ Fresh tissue |
4-5 weeks |
ONCNGS045 |
BRCause NGS Panel - Full sequencing of BRCA1 and BRCA2
|
NGS |
Blood in EDTA |
4-5 weeks |
ONCNGS046 |
BRCause Extended NGS Panel - Full sequencing of BRCA1, BRCA2, ATM, BRIP1, NBN, RAD51C, RAD51D, PALB2, STK11, CHEK2, PTEN, TP53, CDH1, MLH1, MSH2, MSH6, PMS2, APC, SMAD4, BLM, FANCC, ERCC2 and EPCAM genes |
NGS |
Blood in EDTA |
4-5 weeks |
ONCMLP203 |
BRCopy: BRCA1, BRCA2 copy number variations and large gene rearrangements |
MLPA |
Blood in EDTA |
10 days |
ONCNGS393 |
Germline panel for FAP (Familial Adenomatous Polyposis) (Next Generation Sequencing of APC, MUTYH genes) |
NGS |
Blood in EDTA |
4-5 weeks |
ONCNGS241 |
Germline Panel for Hereditary Non-polyposis Colorectal Carcinoma (HNPCC)/ Lynch Syndrome (Next Generation Sequencing of EPCAM, MLH1, MSH2, MSH6 and PMS2) |
NGS |
Blood in EDTA |
4-5 weeks |
ONCNGS244 |
Next Generation Sequencing panel for Multiple Endocrine Neoplasia (MEN) including RET and MEN1 genes |
NGS |
Blood in EDTA |
4-5 weeks |
ONCNGS248 |
Retinoblastoma (RB1 gene Next Generation Sequencing) |
NGS |
Blood in EDTA |
4-5 weeks |
ONCFRG429 |
Microsatellite Instability (MSI) by Fragment analysis |
Fragment Analysis |
FFPE Blocks/ Tissue + Blood in EDTA |
2 weeks |
ONCMLP389 |
MLPA for Von Hippel Lindau (VHL) Syndrome |
MLPA |
Blood in EDTA |
10 days |
NEPSEQ272 |
Von Hippel Lindau Syndrome (Sequencing of exons 1, 2 and 3 of the VHL gene) |
CE-Seq |
Blood in EDTA |
2-3 weeks |
ONCSEQ399 |
Targeted sequencing in VHL, gene (for family members at risk) |
CE-Seq |
Blood in EDTA |
2 weeks |
INDHC2440 |
Human Papillomavirus (HPV) testing for Cervical Cancer Risk by HC2 |
Hybrid Capture 2 |
Cervical specimen in SurePath collection vial |
Every Thursday |
INDNGS441 |
Human Papillomavirus (HPV) genotyping by NGS (RUO) |
NGS |
Cervical specimen in SurePath collection vial |
4-5 weeks |
Use left/right arrows to navigate the slideshow or swipe left/right if using a mobile device